Susquehanna International Group, LLP Kezar Life Sciences, Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$1.08 - $2.54 $216 - $508	-200 Reduced 0.25%	78,800 $93,000
Q1 2023 May 16, 2023	SELL	$3.13 - $7.31 $30,048 - $70,176	-9,600 Reduced 10.84%	79,000 $247,000
Q4 2022 Feb 14, 2023	BUY	$6.39 - $8.8 $327,168 - $450,560	51,200 Added 136.9%	88,600 $623,000
Q3 2022 Nov 14, 2022	SELL	$7.99 - $10.75 $1.4 Million - $1.89 Million	-175,800 Reduced 82.46%	37,400 $322,000
Q2 2022 Aug 15, 2022	BUY	$4.58 - $17.13 $181,826 - $680,061	39,700 Added 22.88%	213,200 $1.76 Million
Q1 2022 May 16, 2022	BUY	$12.3 - $18.33 $1.63 Million - $2.43 Million	132,400 Added 322.14%	173,500 $2.88 Million
Q4 2021 Feb 14, 2022	SELL	$7.44 - $16.72 $266,352 - $598,576	-35,800 Reduced 46.55%	41,100 $687,000
Q2 2020 Aug 14, 2020	BUY	$3.6 - $7.75 $276,840 - $595,975	76,900 New	76,900 $398,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $510M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.